Tuberculosis control- Is dots the health breakthrough of the 1990s?

World Health Forum

Volumn 18, Issue 3-4, 1997, Pages 225-243

  Kochi, Arata ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

CONTROL STRATEGY; DISEASE CONTROL; TUBERCULOSIS;

ARTICLE; COST EFFECTIVENESS ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIOSIS; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

EID: 0031422087     PISSN: 02512432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Dholakia R. The potential economic benefits of the DOTS strategy against TB in India. World Health Organization, 1996 (unpublished document WHO/TB/ 96.218; available on request from the Global TB Programme, World Health Organization, 1211 Geneva 27, Switzerland).